Antithrombotic therapy during percutaneous coronary intervention
- 1 January 1995
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 2 (1), 21-28
- https://doi.org/10.1007/bf01063157
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplastyJournal of the American College of Cardiology, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- The emergence of thrombocardiolgyJournal of Thrombosis and Thrombolysis, 1994
- Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectorisThe American Journal of Cardiology, 1990
- Three days of heparin pretreatment reduces major complications of coronary angioplasty in patients with unstable anginaJournal of the American College of Cardiology, 1990
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988